Skip to main content

Advertisement

Log in

Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

A 63-year-old woman presented with leukocytosis (278 × 109/L) with 72% blasts. Bone marrow blast cells showed cytogenetic abnormality with 46,XX, t(9;22), inv(16). Despite achievement of hematological remission by induction chemotherapy, Philadelphia chromosome did not disappear; chronic myeloid leukemia (CML) in blast crisis (BC) was thus diagnosed. The P190 BCR/ABL fusion transcript was detected. Imatinib mesylate introduced a hematological remission of short duration; however, infiltration into the central nervous system occurred, and the patient died 7 months after presentation. Coexistence of inv(16) and t(9:22) has been described in CML-BC and de novo AML, and CML-BC patients always carry P210 BCR/ABL, while de novo AML patients usually have P190 BCR/ABL. To the best of our knowledge, this is the first report of CML-BC with inv(16) and P190 BCR/ABL. We discuss this case with reference to the literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, et al. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature. 1983;306:277–80.

    Article  CAS  PubMed  Google Scholar 

  2. Laurent E, Talpaz M, Kantarjian H, Kurzrock R. The BCR gene and Philadelphia chromosome-positive leukemogenesis. Cancer Res. 2001;61:2343–55.

    CAS  PubMed  Google Scholar 

  3. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M. Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med. 2003;138:819–30.

    Article  CAS  PubMed  Google Scholar 

  4. Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med. 1987;83:445–54.

    Article  CAS  PubMed  Google Scholar 

  5. Griesshammer M, Heinze B, Hellmann A, Popp C, Anger B, Heil G, et al. Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients. Ann Hematol. 1996;73:225–30.

    Article  CAS  PubMed  Google Scholar 

  6. Ruff P, Saragas E, Poulos M, Weaving A. Patterns of clonal evolution in transformed chronic myelogenous leukemia. Cancer Genet Cytogenet. 1995;81:182–4.

    Article  CAS  PubMed  Google Scholar 

  7. Wu Y, Slovak ML, Snyder DS, Arber DA. Coexistence of inversion 16 and the Philadelphia chromosome in acute and chronic myeloid leukemias: report of six cases and review of literature. Am J Clin Pathol. 2006;125:260–6.

    Article  PubMed  Google Scholar 

  8. Merzianu M, Medeiros LJ, Cortes J, Yin C, Lin P, Jones D, et al. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005;124:807–14.

    Article  CAS  PubMed  Google Scholar 

  9. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia. 1995;9:628–33.

    CAS  PubMed  Google Scholar 

  10. Tsuboi K, Komatsu H, Miwa H, Iida S, Banno S, Wakita A, et al. Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22). Leuk Res. 2002;26:771–4.

    Article  CAS  PubMed  Google Scholar 

  11. Myint H, Ross FM, Hall JL, Hamblin TJ. Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia. Leuk Res. 1997;21:473–4.

    Article  CAS  PubMed  Google Scholar 

  12. Evers JP, Bagg A, Himoe E, Zwiebel JA, Jacobson RJ. Temporal association of marrow eosinophilia with inversion of chromosome 16 in recurrent blast crises of chronic myelogenous leukemia. Cancer Genet Cytogenet. 1992;62:134–9.

    Article  CAS  PubMed  Google Scholar 

  13. Asou N, Sanada I, Tanaka K, Hidaka M, Suzushima H, Matsuzaki H, et al. Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia. Cancer Genet Cytogenet. 1992;61:197–200.

    Article  CAS  PubMed  Google Scholar 

  14. Enright H, Weisdorf D, Peterson L, Rydell RE, Kaplan ME, Arthur DC. Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. Leukemia. 1992;6:381–4.

    CAS  PubMed  Google Scholar 

  15. Heim S, Christensen BE, Fioretos T, Sorensen AG, Pedersen NT. Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet. 1992;59:35–8.

    Article  CAS  PubMed  Google Scholar 

  16. Secker-Walker LM, Morgan GJ, Min T, Swansbury GJ, Craig J, Yamada T, et al. Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases. Cancer Genet Cytogenet. 1992;58:29–34.

    Article  CAS  PubMed  Google Scholar 

  17. Li YS, Hayhoe FG. Ph1 chromosome positive acute myelomonocytic leukaemia with inverted chromosome 16. Br J Haematol. 1988;69:576.

    Article  CAS  PubMed  Google Scholar 

  18. Miura I, Takatsu H, Yamaguchi A, Hashimoto K, Nimura T, Nishinari T, et al. Standard Ph chromosome, t(9;22)(q34;q11), as an additional change in a patient with acute myelomonocytic leukemia (M4Eo) associated with inv(16)(p13q22). Am J Hematol. 1994;45:94–6.

    Article  CAS  PubMed  Google Scholar 

  19. Marcucci G, Caligiuri MA, Dohner H, Archer KJ, Schlenk RF, Dohner K, et al. Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia. Leukemia. 2001;15:1072–80.

    Article  CAS  PubMed  Google Scholar 

  20. Siddiqui AD, Sheikh ZS, Liu D, Seiter K. Coexistence of inversion 16 and the Philadelphia chromosome in patients with acute myelogenous leukemia. Leuk Lymphoma. 2002;43:1137–40.

    Article  PubMed  Google Scholar 

  21. Tirado CA, Valdez F, Klesse L, Karandikar NJ, Uddin N, Arbini A, et al. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3′CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review. Cancer Genet Cytogenet. 2010;200:54–9.

    Article  CAS  PubMed  Google Scholar 

  22. Roth CG, Contis L, Gupta S, Agha M, Safyan E. De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB-MYH11): report of two cases and review of the literature. Leuk Lymphoma. 2011;52(3):531–5.

    Article  PubMed  Google Scholar 

  23. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983;309:630–6.

    Article  CAS  PubMed  Google Scholar 

  24. Marlton P, Claxton DF, Liu P, Estey EH, Beran M, LeBeau M, et al. Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood. 1995;85:772–9.

    CAS  PubMed  Google Scholar 

  25. Preudhomme C, Lai JL, Plantier I, Demory JL, Zandecki M, Fenaux P. Cytogenetic and molecular remission in a case of acute myeloid leukaemia(AML) with inversion of chromosome 16 (Inv(16)) and Philadelphia chromosome (Ph). Br J Haematol. 1992;82:623–6.

    Article  CAS  PubMed  Google Scholar 

  26. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88:2375–84.

    CAS  PubMed  Google Scholar 

  27. Cividin M, Brizard F, Sorel N, Renaud M, Guilhot F, Brizard A. p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22). Leuk Res. 2004;28:97–9.

    Article  CAS  PubMed  Google Scholar 

  28. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood. 2002;99:3530–9.

    Article  CAS  PubMed  Google Scholar 

  29. Shah NP, Nicoll JM, Nagar B, Gorre ME, Paquette RL, Kuriyan J, et al. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (ST1571) in chronic phase and blast crisis chronic myeloid leukemia. Cancer Cell. 2002;2:117–25.

    Article  CAS  PubMed  Google Scholar 

  30. Cortes J, Rousselot P, Kim DW, Ritchie E, Hamerschlak N, Coutre S, et al. Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis. Blood. 2007;109:3207–13.

    Article  CAS  PubMed  Google Scholar 

  31. Wang Y, Wu D, Sun A, Jin Z, Qiu H, Miao M, et al. Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisis. Int J Hematol. 2008;87:167–71.

    Article  CAS  PubMed  Google Scholar 

  32. Verma D, Kantarjian HM, Jones D, Luthra R, Borthakur G, Verstovsek S, et al. Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance. Blood. 2009;114:2232–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hisashi Tsurumi.

About this article

Cite this article

Ninomiya, S., Kanemura, N., Tsurumi, H. et al. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Int J Hematol 93, 806–810 (2011). https://doi.org/10.1007/s12185-011-0854-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0854-3

Keywords

Navigation